Disorder of Synovium and Tendon – Cannabis Research

Disorder of Synovium and Tendon Research Dashboard


Primary Studies


Related Studies


Total Studies

Clinical Studies


Clinical Meta-analyses


Double-blind human trials


Clinical human trials

Pre-Clinical Studies




Animal studies


Laboratory studies

What am I missing as a non-subscriber?

To see a full dashboard with study details and filtering, go to our DEMO page.

As a subscriber, you will be able to access dashboard insights including chemotype overviews and dosing summaries for medical conditions and organ system and receptor breakdowns for cannabinoid and terpene searches. Study lists present important guidance including dosing and chemotype information with the ability to drill down to the published material. And all outputs are fully filterable, to help find just the information you need. Stay up-to-date with the science of cannabis and the endocannabinoid system with CannaKeys.

CannaKeys has 1 studies associated with Disorder of Synovium and Tendon.

Here is a small sampling of Disorder of Synovium and Tendon studies by title:

Components of the Disorder of Synovium and Tendon Research Dashboard

  • Dosing information available for Disorder of Synovium and Tendon
  • Chemotype guidance for treating Disorder of Synovium and Tendon with cannabis
  • Synopsis of cannabis research for Disorder of Synovium and Tendon
  • Individual study details for Disorder of Synovium and Tendon

Ready to become a subscriber? Go to our PRICING page.

Select New Condition

Search By Keyword

Filter Condition

Members can filter by the following criteria:

  • Study Type
  • Chemotype
  • Cannabinoids & Endocannabinoids
  • Terpenes
  • Receptors
  • Ligands
  • Study Result
  • Year of Publication

Overview - Disorder of Synovium and Tendon

Description of Disorder of Synovium and Tendon

A tendon is comprised of strong connective tissue that connects a muscle to a bone. For instance, the Achilles tendon starts at the base of the heel bone and connects it to the base of the calf muscle. It is named after the legendary Greek warrior Achilles of the Trojan war who was, as legend goes, invincible but for one vulnerability—his heel. The specific causes of tendinopathy are still subject to scientific investigation but contributing cause may include: micro tears, repetitive motion stress, certain pharmaceutical drugs (i.e. quinolone-based antibiotics), weight-related ischemia, or other conditions (e.g. arthritis, diabetes) for instance. And, while inflammation may play a role in some aspects of tendinopathy the microscopic lack of inflammatory cytokines puts tendinopathy outside the typical inflammatory disease classification.

Disease Classification

Condition: Tendon Disorders
Disease Family:
Organ System: Muscular System, Skeletal System
ICD-10 Chapter: Diseases of the musculoskeletal system and connective tissue
ICD-10 Code: M67

Disorder of Synovium and Tendon Symptoms:

The Achilles is the strongest tendon in the human body and if chronically affected, can produce significant pain in the surrounding tissues, swelling, as well as disability, a condition commonly referred to as tendinopathy. When tendinopathy progresses to show actual structural changes in the affected tissues (e.g. neovascularization, degeneration, tenocytes), usually in the center of the tendon, it is referred to as tendinopathy.

Also known as:

Synovial hypertrophy, Achilles Tendinosis

Drug Interactions

THC Interaction with Pharmaceutical Drugs

  • THC can enhance the effects of drugs that cause sedation and depress the central nervous system, such as benzodiazepines, barbiturates, and alcohol, for example. 
  • THC is metabolized by and an inhibitor of a number of enzymatic liver pathways referred to as cytochrome P450. There are more than 50 enzymes belonging to this enzyme family, a number of which are responsible for the breakdown of common drugs such as antidepressants (e.g. amitriptyline, doxepine, fluvoxamine), antipsychotics (haloperidol, clozapine, stelazine), beta-blockers (e.g. propranolol), bronchodilators (e.g. theophylline), or bloodthinners (e.g. warfarin).  Thus patients taking these classes of medication may find that THC increases the concentration and effects of these drugs as well as the duration of their effects.
  • Clinical observation suggests no likely interactions with other pharmaceuticals at a total daily dose of up to 20mg THC.

CBD Interaction with Pharmaceutical Drugs

  • CBD may alter action on metabolic enzymes (certain drug-transport mechanisms), and as such may alter interactions with other drugs, some of which may produce therapeutic or adverse effects. For instance, CBD interacts with the enzyme cytochrome P450 3A4 and cytochrome P450 2C19, increasing the bioavailability of anti-epileptic drugs such as clobazam (a benzodiazepine). This makes it possible to achieve the same results at significantly lower dosages, reducing treatment costs and risks of adverse effects. 
  • Groups of drugs affected include: anti-epileptic drugs, psychiatric drugs, and drugs affecting metabolic enzymes, for example.
  • Clinical observations suggest no likely interactions with other pharmaceuticals at a total daily dose of up to 100mg CBD

Dosing Considerations

THC Dosage Considerations

  • THC micro dose:  0.1 mg to 0.4 mg
  • THC low dose:  0.5 mg to 5 mg
  • THC medium dose:  6 mg to 20 mg
  • THC high dose:  21 mg to 50+ mg

CBD Dosage Considerations

  • CBD low dose:  0.4 mg to 19 mg
  • CBD medium dose: 20 mg to 99 mg
  • CBD high dose:  100 mg to 800+ mg (upper limits tested ~1,500mg)

Disclaimers: Information on this site is provided for informational purposes only and is not meant to substitute for the advice provided by your own physician or other medical professional. You should not use the information contained herein for diagnosing a health problem or disease. If using a product, you should read carefully all product packaging. If you have or suspect that you have a medical problem, promptly contact your health care provider.

Information on this site is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. For many of the conditions discussed, treatment with prescription or over-the-counter medication is also available. Consult your physician, nutritionally oriented health care practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications.